View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. Market Data
July 2, 2017

Non-industry trials were more frequent than industry trials in 2016

As part of a series of white papers tracking clinical trial activity around the world, GlobalData covered 14,190 trials initiated in 2016 across all diseases and phases that had a start date between 1 January and 31 December 2016.

By GlobalData Healthcare

As part of a series of white papers tracking clinical trial activity around the world, GlobalData covered 14,190 trials initiated in 2016 across all diseases and phases that had a start date between 1 January and 31 December 2016.

GlobalData analysed the number of trials carried out by industry and non-industry sponsors and determined the top sponsors and contract research organisations (CRO) involved in these clinical trials, as well as the top investigational drugs.

Non-industry trials outnumbered industry-sponsored trials across the yearly period (Figure 1). Clinical trials were more frequently run in single countries than across multinational regions and the five major therapy areas were oncology, central nervous system, cardiovascular, infectious disease, and metabolic disorders.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU